Eicosapentaenoic acid modulates cyclin expression and arrests cell cycle progression in human leukemic K-562 cells

Int J Oncol. 2001 Oct;19(4):845-9. doi: 10.3892/ijo.19.4.845.

Abstract

Eicosapentaenoic acid (EPA) is a polyunsaturated fatty acid (20:5omega3) found primarily in aquatic organisms. We have shown previously that EPA inhibits the growth but is not toxic to human leukemic K-562 cells. In this study, the anti-proliferative effect of EPA on the leukemic cells was further determined and its impacts on cell cycle progression and cyclin expression were investigated. EPA inhibited proliferation of K-562 cells, which was associated with accumulation of G0/G1 cells and down-regulation of cyclin E expression. Cyclin B1-expressing cells were also reduced showing that down-regulation of cyclin expression might be important in the anti-proliferation of EPA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Cell Cycle / drug effects*
  • Cyclin B / metabolism*
  • Cyclin B1
  • Cyclin E / metabolism*
  • Down-Regulation
  • Eicosapentaenoic Acid / pharmacology*
  • Flow Cytometry
  • G1 Phase / drug effects
  • Humans
  • K562 Cells / drug effects*
  • K562 Cells / metabolism
  • Resting Phase, Cell Cycle / drug effects

Substances

  • CCNB1 protein, human
  • Cyclin B
  • Cyclin B1
  • Cyclin E
  • Eicosapentaenoic Acid